EUVIMEDEUVIMED entdecken
Leitlinie

Nationwide Trends in Helicobacter pylori Eradication Therapies in Korea: Impact of Guideline Updates on Treatment Practices

Byung Wook Jung iD, Yun Jin Kim, Chan Hyuk Park iD

Helicobacter · 2024

DOI: 10.1111/hel.13152 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Helicobacter, 2024. Verfasst von Byung Wook Jung und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Republic of Korea. Hauptthemen laut MEDLINE: Helicobacter Infections, Helicobacter pylori, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Helicobacter pylori infects over 50% of the global population, prompting the issuance of guidelines for effective diagnosis and treatment. However, research on guideline dissemination and adherence is limited. Therefore, we assessed the nationwide status of H. pylori eradication therapies in Korea before and after guideline updates.

Methods

Using data from the Korean National Health Insurance Service, this retrospective cohort study analyzed changes in H. pylori eradication therapies across three periods: Phase I (2006–2007), Phase II (2014–2015), and Phase III (2021–2022). It examined therapy regimens, confirmation tests, and retreatment rates.

Results

Among 1,657,746 patients included, the number undergoing eradication therapy increased across the phases (Phase I: 234,365; Phase II: 493,889; Phase III: 929,492). The use of conventional triple therapy declined from 96.1% in Phase I to 88.3% in Phase III, while non‐bismuth and bismuth quadruple therapies increased to 6.8% and 3.3%, respectively, in Phase III. The proportion of patients following a 1‐week regimen of conventional triple therapy decreased from 90.3% in Phase I to 54.2% in Phase III, while a 2‐week regimen increased to 36.1% in Phase III. Confirmation testing within 1 year of therapy increased from 21.3% in Phase I to 43.0% in Phase III, whereas retreatment rates increased from 3.8% in Phase I to 8.8% in Phase III.

Conclusions

Guideline updates have influenced H. pylori eradication practices in Korea, leading to increased use of quadruple therapies with longer treatment durations. However, further improvements in confirmatory tests and retreatment following failed initial therapy are required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter InfectionsHelicobacter pyloriAnti-Bacterial AgentsHumansRepublic of KoreaRetrospective StudiesMaleMiddle AgedFemaleAdultAgedDrug Therapy, CombinationYoung AdultPractice Guidelines as TopicGuideline AdherenceAdolescentAged, 80 and overProton Pump Inhibitors

Stichwörter der Autor:innen

Helicobacter pyloriguidelinestesttreatment

Substanzen

Anti-Bacterial AgentsProton Pump Inhibitors

Autor:innen und Institutionen

  • Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Republic of Korea.
  • Department of Medicine, Graduate School, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Department of Medicine, College of Medicine, Hanyang University, Seoul, Republic of Korea.
  • Biostatistics Lab, Medical Research Collaborating Center, Hanyang University, Seoul, Republic of Korea.
  • Department of Internal Medicine, Chung-Ang University H.C.S. Hyundae Hospital, Namyangju, Republic of Korea.

ORCID-Profile: Byung Wook Jung, Chan Hyuk Park

Zitieren

APA

Jung, B. W., Kim, Y. J., & Park, C. H. (2024). Nationwide Trends in Helicobacter pylori Eradication Therapies in Korea: Impact of Guideline Updates on Treatment Practices. Helicobacter. https://doi.org/10.1111/hel.13152

Vancouver

Jung BW, Kim YJ, Park CH. Nationwide Trends in Helicobacter pylori Eradication Therapies in Korea: Impact of Guideline Updates on Treatment Practices. Helicobacter. 2024. doi:10.1111/hel.13152

BibTeX
@article{Jung2024,
  author = {Jung, Byung Wook and Kim, Yun Jin and Park, Chan Hyuk},
  title = {Nationwide Trends in Helicobacter pylori Eradication Therapies in Korea: Impact of Guideline Updates on Treatment Practices},
  journal = {Helicobacter},
  year = {2024},
  doi = {10.1111/hel.13152}
}
Kostenlos starten →